Solid Dispersions as a Drug Delivery System |
Kim, Ki-Taek
(College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lee, Jae-Young (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Lee, Mee-Yeon (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Song, Chung-Kil (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Choi, Joon-Ho (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Kim, Dae-Duk (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) |
1 | Gines, J.M., Arias, M.J., Moyano, J.R., Sanchezsoto, P.J., 1996. Thermal investigation of crystallization of polyethylene glycols in solid dispersions containing oxazepam. Int. J. Pharm. 143, 247-253. DOI |
2 | Goldberg, A.H., Gibaldi, M., Kanig, J.L., 1965. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J. Pharm. Sci. 54, 1145-1148. DOI |
3 | Damian, F., Blaton, N., Naesens, L., Balzarini, J., Kinget, R., Augustijns, P., Van den Mooter, G., 2000. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 10, 311-322. DOI |
4 | Desai, J., Alexander, K., Riga, A., 2006. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int. J. Pharm. 308, 115-123. DOI |
5 | Dhirendra, K., Lewis, S., Udupa, N., Atin, K., 2009. Solid dispersions: a review. Pak. J. Pharm. Sci. 22, 234-246. |
6 | Doherty, C., York, P., 1989. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions. J. Pharm. Pharmacol. 41, 73-78. DOI |
7 | Dubois, J.L., Ford, J.L., 1985. Similarities in the release rates of different drugs from polyethylene glycol 6000 solid dispersions. J. Pharm. Pharmacol. 37, 494-495. DOI |
8 | El-Zein, H., Riad, L., Elbary, A.A., 1998. Enhancement of carbamazepine dissolution - in vitro and in vivo evaluation. Int. J. Pharm. 168, 209-220. DOI |
9 | Fawaz, F., Bonini, F., Guyot, M., Bildet, J., Maury, M., Lagueny, A.M., 1996. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. Int. J. Pharm. 132, 271-275. DOI |
10 | Zingone, G., Rubessa, F., 1994. Release of carbamazepine from solid dispersions with polyvinylpyrrolidone/vinylacetate copolymer (PVP/VA). S.T.P. Pharm. Sci. 4, 122-127. DOI |
11 | Fernandez, M., Margarit, M.V., Rodriguez, I.C., Cerezo, A., 1993. Dissolution kinetics of piroxicam in solid dispersions with polyethylene glycol-4000. Int. J. Pharm. 98, 29-35. DOI |
12 | Ford, J.L., A.F., S., Dubois, J.L., 1986. The properties of solid dispersions of indomethacin or phenylbutazone in polyethylene glycol. Int. J. Pharm. 28, 11-22. DOI |
13 | Ford, J.L., and Rubinstein, M.H., 1980. Formulation and Aging of Tablets Prepared from Indomethacin-Polyethylene Glycol 6000 Solid Dispersions. Pharmaceutica Acta. Helvetiae. 55, 1-7. |
14 | Chiou, W.L., Riegelma.S, 1970. Oral Absorption of Griseofulvin in Dogs - Increased Absorption Via Solid Dispersion in Polyethylene Glycol-6000. J. Pharm. Sci. 59, 937-942. DOI |
15 | Chiou, W.L., Riegelman, S., 1969. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J. Pharm. Sci. 58, 1505-1510. DOI |
16 | Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60, 1281-1302. DOI |
17 | Cho, S.W., Lee, J.S., Choi, S.H., 2004. Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex. Journal of Pharmaceutical Sciences. 93, 612-620. DOI |
18 | Chokshi, R.J., Shah, N.H., Sandhu, H.K., Malick, A.W., Zia, H., 2008. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. J. Pharm. Sci. 97, 2286-2298. DOI |
19 | Chutimaworapan, S., Ritthidej, G.C., Yonemochi, E., Oguchi, T., Yamamoto, K., 2000. Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions. Drug Development and Industrial Pharmacy. 26, 1141-1150. DOI |
20 | Vippagunta, S.R., Maul, K.A., Tallavajhala, S., Grant, D.J., 2002. Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. 236, 111-123. DOI ScienceOn |
21 | Vippagunta, S.R., Wang, Z., Hornung, S., Krill, S.L., 2007. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J. Pharm. Sci. 96, 294-304. DOI |
22 | Walking, W.D., 1994. Povidone. Handbook of Pharmaceutical Excipients. DOI ScienceOn |
23 | Watanabe, T., Ohno, I., Wakiyama, N., Kusai, A., Senna, M., 2002. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture. Int. J. Pharm. 241, 103-111. DOI |
24 | Weuts, I., Kempen, D., Verreck, G., Decorte, A., Heymans, K., Peeters, J., Brewster, M., Van den Mooter, G., 2005. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 59, 119-126. DOI |
25 | Won, D.H., Kim, M.S., Lee, S., Park, J.S., Hwang, S.J., 2005. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 301, 199-208. DOI |
26 | Yagi, N., Terashima, Y., Kenmotsu, H., Sekikawa, H., Takada, M., 1996. Dissolution behavior of probucol from solid dispersin systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 44, 241-244. DOI |
27 | Bergh, M., Magnusson, K., Nilsson, J.L. Karlberg, A.T., 1998a. Formation of formaldehyde and peroxides by air oxidation of high purity polyoxyethylene surfactants. Contact Dermatitis. 39, 14-20. DOI |
28 | Corrigan, O.I., Healy, A.M., 2002. Surface active carriers in pharmaceutical products and system. Encyclopedia of pharmaceutical technology. 3, 2639-2653. |
29 | Corrigan, O.I., Timoney, R.F., Whelan, M.J., 1976. The influence of polyvinylpyrrolidone on the solution and bioavailability of hydrochlorothiazide. J. Pharm. Pharmacol. 28, 703-706. DOI |
30 | Damian, F., Blaton, N., Kinget, R., Van den Mooter, G., 2002. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int. J. Pharm. 244, 87-98. DOI |
31 | Bergh, M., Shao, L.P., Hagelthorn, G., Gafvert, E., Nilsson, J.L.G., Karlberg, A.T., 1998b. Contact allergens from surfactants. Atmospheric oxidation of polyoxyethylene alcohols, formation of ethoxylated aldehydes, and their allergenic activity. J. Pharm. Sci. 87, 276-282. DOI |
32 | Bikiaris, D., 2005. Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim. Acta. 439, 58-67. DOI ScienceOn |
33 | Bindra, D.S., Williams, T.D., Stella, V.J., 1994. Degradation of O-6-Benzylguanine in Aqueous Polyethylene-Glycol-400 (Peg-400) Solutions - Concerns with Formaldehyde in Peg-400. Pharm. Res. 11, 1060-1064. DOI |
34 | Breitenbach, J., 2002. Melt extrusion: from process to drug delivery technology. European Journal of Pharmaceutics and Biopharmaceutics. 54, 107-117. DOI |
35 | van Drooge, D.J., Braeckmans, K., Hinrichs, W.L.J., Remaut, K., De Smedt, S.C., Frijlink, H.W., 2006a. Characterization of the mode of incorporation of lipophilic compounds in solid dispersions at the nanoscale using fluorescence resonance energy transfer (FRET). Macromol Rapid Comm. 27, 1149-1155. DOI |
36 | Yao, W.W., Bai, T.C., Sun, J.P., Zhu, C.W., Hu, J., Zhang, H.L., 2005. Thermodynamic properties for the system of silybin and poly(ethylene glycol) 6000. Thermochim. Acta. 437, 17-20. DOI |
37 | Yoshihashi, Y., Iijima, H., Yonemochi, E., Terada, K., 2006. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J. Therm. Anal Calorim. 85, 689-692. DOI |
38 | Van den Mooter, G., Wuyts, M., Blaton, N., Busson, R., Grobet, P., Augustijns, P., Kinget, R., 2001. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12, 261-269. DOI |
39 | van Drooge, D.J., Hinrichs, W.L., Visser, M.R., Frijlink, H.W., 2006b. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int. J. Pharm. 310, 220-229. DOI |
40 | Vasconcelos, T., Sarmento, B., Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today. 12, 1068-1075. DOI |
41 | Verreck, G., Chun, I., Peeters, J., Rosenblatt, J., Brewster, M.E., 2003a. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res. 20, 810-817. DOI |
42 | Chiou, W.L., 1977. Pharmaceutical applications of solid dispersion systems: X-ray diffraction and aqueous solubility studies on griseofulvin-polyethylene glycol 6000 systems. J. Pharm. Sci. 66, 989-991. DOI |
43 | Ceballos, A., Cirri, M., Maestrelli, F., Corti, G., Mura, P., 2005. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco. 60, 913-918. DOI |
44 | Chaudhari.P.D., S.P.K., 2006. Current trends in solid dispersions techniques. Pharmaceutical Reviews. 4. |
45 | Chauhan, B., Shimpi, S., Paradkar, A., 2005. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 26, 219-230. DOI ScienceOn |
46 | Tashtoush, B.M., Al-Qashi, Z.S., Najib, N.M., 2004. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Development and Industrial Pharmacy. 30, 601-607. DOI |
47 | Verreck, G., Decorte, A., Heymans, K., Adriaensen, J., Liu, D., Tomasko, D., Arien, A., Peeters, J., Van den Mooter, G., Brewster, M.E., 2006a. Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. Int. J. Pharm. 327, 45-50. DOI |
48 | Verreck, G., Six, K., Van den Mooter, G., Baert, L., Peeters, J., Brewster, M.E., 2003b. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I. Int. J. Pharm. 251, 165-174. DOI |
49 | Vilhelmsen, T., Eliasen, H., Schaefer, T., 2005. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int. J. Pharm. 303, 132-142. DOI ScienceOn |
50 | Taylor, L.S., Zografi, G., 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14, 1691-1698. DOI |
51 | Timko, R.J., Lordi, N.G., 1984. Thermal-Analysis Studies of Glass Dispersion-Systems. Drug Development and Industrial Pharmacy. 10, 425-451. DOI |
52 | Torrado, S., Torrado, J.J., Cadorniga, R., 1996. Preparation, dissolution and characterization of albendazole solid dispersions. Int. J. Pharm. 140, 247-250. DOI |
53 | Trapani, G., Franco, M., Latrofa, A., Pantaleo, M.R., Provenzano, M.R., Sanna, E., Maciocco, E., Liso, S., 1999. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int. J. Pharm. 184, 121-130. DOI |
54 | Van den Mooter, G., Weuts, I., De Ridder, T., Blaton, N., 2006. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int. J. Pharm. 316, 1-6. DOI ScienceOn |
55 | Ali, A.A., Gorashi, A.S., 1984. Absorption and dissolution of nitrofurantoin from different experimental formulations. Int. J. Pharm. 19, 297-306. DOI |
56 | Andronis, V., Yoshioka, M., Zografi, G., 1997. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 86, 346-351. DOI |
57 | Turk, M., Helfgen, B., Hils, P., Lietzow, R., Schaber, K., 2002. Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): Experiments and modeling. Particle & Particle Systems Characterization. 19, 327-335. DOI |
58 | Urbanetz, N.A., 2006. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur. J. Pharm. Sci. 28, 67-76. DOI |
59 | Valizadeh, H., Nokhodchi, A., Qarakhani, N., Zakeri-Milani, P., Azarmi, S., Hassanzadeh, D., Lobenberg, R., 2004. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm. 30, 303-317. DOI |
60 | Stoll, R.G., Bates, T.R., Nieforth, K.A., Swarbrick, J., 1969. Some physical factors affecting the enhanced blepharoptotic activity of orally administered reserpine-cholanic acid coprecipitates. J. Pharm. Sci. 58, 1457-1459. DOI |
61 | Streubel, A., 2006. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr. Opin. Pharmacol. 6, 501-508. DOI ScienceOn |
62 | Subramaniam, B., Rajewski, R.A., Snavely, K., 1997. Pharmaceutical processing with supercritical carbon dioxide. Journal of Pharmaceutical Sciences. 86, 885-890. DOI |
63 | Suzuki, H., Miyamoto, N., Masada, T., Hayakawa, E., Ito, K., 1996. Solid dispersions of benidipine hydrochloride. 1. Preparations using different solvent systems and dissolution properties. Chem. Pharm. Bull 44, 364-371. DOI |
64 | Tanaka, N., Imai, K., Okimoto, K., Ueda, S., Tokunaga, Y., Ohike, A., Ibuki, R., Higaki, K., Kimura, T., 2005. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J. Control Release. 108, 386-395. DOI |
65 | Suzuki, H., Sunada, H., 1997. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem. Pharm. Bull. (Tokyo) 45, 1688-1693. DOI ScienceOn |
66 | Suzuki, H., Sunada, H., 1998. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem. Pharm. Bull. (Tokyo) 46, 482-487. DOI ScienceOn |
67 | Tanaka, N., Imai, K., Okimoto, K., Ueda, S., Tokunaga, Y., Ibuki, R., Higaki, K., Kimura, T., 2006. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. J. Control Release. 112, 51-56. DOI |
68 | Tantishaiyakul, V., Kaewnopparat, N., Ingkatawornwong, S., 1999. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 181, 143-151. DOI |
69 | Serajuddin, A.T., Sheen, P.C., Mufson, D., Bernstein, D.F., Augustine, M.A., 1988. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. Journal of Pharmaceutical Sciences. 77, 414-417. DOI |
70 | Sethia, S., Squillante, E., 2002. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J. Pharm. Sci. 91, 1948-1957. DOI |
71 | Shah, J.C., Chen, J.R., Chow, D., 1995. Preformulation study of etoposide. 2. Increased solubility and dissolution rate by solidsolid dispersions. Int. J. Pharm. 113, 103-111. DOI ScienceOn |
72 | Shukla, A.J., 1994. Polymethacrylates. Handbook of Pharmaceutical Excipients. |
73 | Sheu, M.T., Yeh, C.M., Sokoloski, T.D., 1994. Characterization and dissolution of fenofibrate solid dispersion systems. Int. J. Pharm. 103, 137-146. DOI |
74 | Shimpi, S.L., Chauhan, B., Mahadik, K.R., Paradkar, A., 2005. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharm. Res. 22, 1727-1734. DOI |
75 | Shin, S., Oh, I., Lee, Y., Choi, H., Choi, J., 1998. Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone. Int. J. Pharm. 175, 17-24. DOI |
76 | Simonelli, A.P., Mehta, S.C., Higuchi, W.I., 1969. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J. Pharm. Sci. 58, 538-549. DOI |
77 | Sjokvist, E., Nystrom, C., Alden, M., 1992. Physicochemical aspects of drug release XIV. The effects of some ionic and non-ionic surfactants on properties of a sparingly soluble drug in solid dispersions. Int. J. Pharm. 79, 123-133. DOI |
78 | Ramadan, E.M., Abd El-Gawad, A.H., Nouh, A.T., 1987. Bioavailability and erosive activity of solid dispersions of some non-steroidal anti-inflammatory drugs. Pharm. Ind. 49, 508-513. |
79 | Rasenack, N., and Muller, B.W., 2004. Micron-size drug particles: common and novel micronization techniques. Pharm. Dev. Technol. 9, 1-13. DOI |
80 | Rodier, E., Lochard, H., Sauceau, M., Letourneau, J.J., Freiss, B., Fages, J., 2005. A three step supercritical process to improve the dissolution rate of Eflucimibe. European Journal of Pharmaceutical Sciences. 26, 184-193. DOI |
81 | Sekiguchi, K., Obi, N., Ueda, Y., 1964. Studies on Absorption of Eutectic Mixture. Ii. Absorption of Fused Conglomerates of Chloramphenicol and Urea in Rabbits. Chem. Pharm. Bull. (Tokyo) 12, 134-144. DOI ScienceOn |
82 | Saers, E.S., Nystrom, C., Alden, M., 1993. Physicochemical Aspects of Drug Release .16. The Effect of Storage on Drug Dissolution from Solid Dispersions and the Influence of Cooling Rate and Incorporation of Surfactant. International Journal of Pharmaceutics. 90, 105-118. DOI |
83 | Save, T., Venkitachalam, P., 1992. Studies on Solid Dispersions of Nifedipine. Drug Development and Industrial Pharmacy. 18, 1663-1679. DOI |
84 | Sekiguchi, K., Obi, N., 1961. Studies on Absorption of Eutectic Mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 9, 866-872. DOI |
85 | Seo, A., Schaefer, T., 2001. Melt agglomeration with polyethylene glycol beads at a low impeller speed in a high shear mixer. Eur. J. Pharm. Biopharm. 52, 315-325. DOI |
86 | Serajuddin, A.T., 1999. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88, 1058-1066. DOI |
87 | Owusu-Ababio, G., Ebube, N.K., Reams, R., Habib, M., 1998. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets. Pharm. Dev. Technol. 3, 405-412. DOI |
88 | Paradkar, A., Ambike, A.A., Jadhav, B.K., Mahadik, K.R., 2004. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm. 271, 281-286. DOI ScienceOn |
89 | Perng, C.Y., Kearney, A.S., Patel, K., Palepu, N.R., Zuber, G., 1998. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int. J. Pharm. 176, 31-38. DOI |
90 | Passerini, N., Albertini, B., Gonzalez-Rodriguez, M.L., Cavallari, C., Rodriguez, L., 2002. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur. J. Pharm. Sci. 15, 71-78. DOI |
91 | Pokharkar, V.B., Mandpe, L.P., Padamwar, M.N., Ambike, A.A., Mahadik, K.R., Paradkar, A., 2006. Development, characterization and stabilization of amorphous form of a low T-g drug. Powder Technol. 167, 20-25. DOI |
92 | Pouton, C.W., 2006a. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29, 278-287. DOI |
93 | Pozzi, F., Longo, A., Lazzarini, C., Carenzi, A., 1991. Formulations of Ubidecarenone with Improved Bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. 37, 243-246. |
94 | Prabhu, S., Ortega, M., Ma, C., 2005. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int. J. Pharm. 301, 209-216. DOI |
95 | Price, J.C., 1994. Polyethylene glycol. Handbook of Pharmaceutical Excipients |
96 | Miyazaki, T., Yoshioka, S., Aso, Y., Kojima, S., 2004. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J. Pharm. Sci. 93, 2710-2717. DOI |
97 | Moneghini, M., Carcano, A., Zingone, G., Perissutti, B., 1998. Studies in dissolution enhancement of atenolol. Int. J. Pharm. 175, 177-183. DOI |
98 | Ning, X., Sun, J., Han, X., Wu, Y., Yan, Z., Han, J., He, Z., 2011. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev. Ind. Pharm. |
99 | Muhrer, G., Meier, U., Fusaro, F., Albano, S., Mazzotti, M., 2006. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions. Int. J. Pharm. 308, 69-83. DOI ScienceOn |
100 | Mura, P., Faucci, M.T., Manderioli, A., Bramanti, G., and Parrini, P., 1999. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev. Ind. Pharm. 25, 257-264. DOI |
101 | Ohara, T., 2005. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int. J. Pharm. 302, 95-102. DOI |
102 | Ohara, T., Kitamura, S., Kitagawa, T., Terada, K., 2005. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int. J. Pharm. 302, 95-102. DOI |
103 | Okonogi, S., Oguchi, T., Yonemochi, E., Puttipipatkhachorn, S., Yamamoto, K., 1997a. Improved dissolution of ofloxacin via solid dispersion. Int. J. Pharm. 156, 175-180. DOI |
104 | Okonogi, S., Yonemochi, E., Oguchi, T., Puttipipatkhachorn, S., Yamamoto, K., 1997b. Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Dev. Ind. Pharm. 23, 1115-1121. DOI |
105 | Li, L., AbuBaker, O., Shao, Z.J., 2006. Characterization of poly(ethylene oxide) as a drug carrier in hot-melt extrusion. Drug Dev. Ind. Pharm. 32, 991-1002. DOI |
106 | Lo, W.Y., Law, S.L., 1996. Dissolution behavior of griseofulvin solid dispersions using polyethylene glycol, talc, and their combination as dispersion carriers. Drug Dev. Ind. Pharm. 22, 231-236. DOI |
107 | Lin, C.W., Cham, T.M., 1996. Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 127, 261-272. DOI |
108 | Liu, R., 2008. Water-insoluble drug formulation. 669 p. |
109 | Lloyd, G.R., Craig, D.Q., Smith, A., 1999. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions. Eur. J. Pharm. Biopharm. 48, 59-65. DOI |
110 | Majerik, V., Charbit, G., Badens, E., Horvath, G., Szokonya, L., Bosc, N., Teillaud, E., 2007. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. Journal of Supercritical Fluids. 40, 101-110. DOI |
111 | Margarit, M.V., Rodriquez, I.C., Cerezo, A., 1994. Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. Int. J. Pharm. 108, 101-107. DOI |
112 | Matsumoto, T., Zografi, G., 1999. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm. Res. 16, 1722-1728. DOI |
113 | Mayersohn, M., Gibaldi, M., 1966. New method of solid-state dispersion for increasing dissolution rates. J. Pharm. Sci. 55, 1323-1324. DOI |
114 | Kondo, N., Iwao, T., Hirai, K., Fukuda, M., Yamanouchi, K., Yokoyama, K., Miyaji, M., Ishihara, Y., Kon, K., Ogawa, Y., et al., 1994. Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J. Pharm. Sci. 83, 566-570. DOI |
115 | Khan, G.M., Zhu, J.B., 1998. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol, talc, and peg-talc as dispersion carriers. Drug. Dev. Ind. Pharm. 24, 455-462. DOI |
116 | Khougaz, K., Clas, S.D., 2000. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. J. Pharm. Sci. 89, 1325-1334. DOI |
117 | Kim, K.H., Jarowski, C.I., 1977. Surface tension lowering and dissolution rate of hydrocortisone from solid solutions of selected n-acyl esters of cholesterol. J. Pharm. Sci. 66, 1536-1540. DOI |
118 | Konno, H., and Taylor, L.S., 2006. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J. Pharm. Sci. 95, 2692-2705. DOI ScienceOn |
119 | Konno, H., and Taylor, L.S., 2008. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm. Res. 25, 969-978. DOI |
120 | Langer, M., Holtje, M., Urbanetz, N.A., Brandt, B., Holtje, H.D., and Lippold, B.C., 2003. Investigations on the predictability of the formation of glassy solid solutions of drugs in sugar alcohols. Int. J. Pharm. 252, 167-179. DOI |
121 | Leuenberger, H., 2002. Spray freeze-drying - the process of choice for low water soluble drugs? Journal of Nanoparticle Research. 4, 111-119. DOI |
122 | Kang, B.K., Lee, J.S., Chon, S.K., Jeong, S.Y., Yuk, S.H., Khang, G., Lee, H.B., Cho, S.H., 2004. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274, 65-73. DOI ScienceOn |
123 | Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47-60. DOI |
124 | Jachowicz, R., 1987. Dissolution rates of partially water-soluble drugs from solid dispersion systems. 1. Prednisolone. Int. J. Pharm. 35, 1-5. DOI |
125 | Joshi, H.N., Tejwani, R.W., Davidovich, M., Sahasrabudhe, V.P., Jemal, M., Bathala, M.S., Varia, S.A., Serajuddin, A.T., 2004. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 269, 251-258. DOI |
126 | Kanig, J.L., 1964. Properties of Fused Mannitol in Compressed Tablets. J. Pharm. Sci. 53, 188-192. DOI |
127 | Karatas, A., Yuksel, N., Baykara, T., 2005. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Farmaco. 60, 777-782. DOI |
128 | Karavas, E., Georgarakis, E., Bikiaris, D., 2006a. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 64, 115-126. DOI |
129 | Karavas, E., Ktistis, G., Xenakis, A., Georgarakis, E., 2006b. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur. J. Pharm. Biopharm. 63, 103-114. DOI ScienceOn |
130 | Kassem, A.A., Zaki, S.A., Mursi, N.M., Tayel, S.A., 1979. Chloramphenicol solid dispersion system 1. Pharm. Ind. 41, 390-393. |
131 | Gong, K., Viboonkiat, R., Rehman, I.U., Buckton, G., Darr, J.A., 2005. Formation and characterization of porous indomethacin- PVP coprecipitates prepared using solvent-free supercritical fluid processing. J. Pharm. Sci. 94, 2583-2590. DOI |
132 | Kearney, A.S., Gabriel, D.L., Mehta, S.C., Radebaugh, G.W., 1994. Effect of polyvinylpyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory Ci-987. Int. J. Pharm. 104, 169-174. DOI |
133 | Goldberg, A.H., Gibaldi, M., Kanig, J.L., 1966. Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs Via Solid Solutions and Eutectic Mixtures .2. Experimental Evaluation of a Eutectic Mixture - Urea-Acetaminophen System. Journal of Pharmaceutical Sciences. 55, 482-487. DOI |
134 | Goldberg, A.H., Gibaldi, M., Kanig, J.L., Mayersohn, M., 1966. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol--urea system. J. Pharm. Sci. 55, 581-583. DOI |
135 | Gupta, P., Kakumanu, V.K., Bansal, A.K., 2004. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21, 1762-1769. DOI ScienceOn |
136 | Guyot, M., Fawaz, F., Bildet, J., Bonini, F., Lagueny, A.M., 1995. Physicochemical Characterization and Dissolution of Norfloxacin/Cyclodextrin Inclusion-Compounds and Peg Solid Dispersions. Int. J. Pharm. 123, 53-63. DOI |
137 | Hasegawa, S., Hamaura, T., Furuyama, N., Kusai, A., Yonemochi, E., Terada, K., 2005. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 302, 103-112. DOI |
138 | Forster, A., Hempenstall, J., Rades, T., 2001a. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J. Pharm. Pharmacol. 53, 303-315. DOI ScienceOn |
139 | Hirasawa, N., Ishise, S., Miyata, H., Danjo, K., 2003. Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier. Drug Dev. Ind. Pharm. 29, 339-344. DOI |
140 | Itai, S., Nemoto, M., Kouchiwa, S., Murayama, H., Nagai, T., 1985. Influence of wetting factors on the dissolution behavior of flufenamic acid. Chem. Pharm. Bull. (Tokyo) 33, 5464-5473. DOI ScienceOn |
141 | Forster, A., Hempenstall, J., Tucker, I., Rades, T., 2001b. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm. 226, 147-161. DOI |
142 | Frontini, R., Mielck, J.B., 1995. Formation of Formaldehyde in Polyethyleneglycol and in Poloxamer under Stress Conditions. Int. J. Pharm. 114, 121-123. DOI |
143 | Garcia-Zubiri, I.X., Gonzalez-Gaitano, G., Isasi, J.R., 2006. Thermal stability of solid dispersions of naphthalene derivatives with beta-cyclodextrin and beta-cyclodextrin polymers. Thermochim. Acta. 444, 57-64. DOI |
144 | Gardner, D., 1997. The intelisite capsule: a new easy to use approach for assessing regional drug absorption from gastrointestinal tract. Pharm. Tech. Eur. 9, 46-53. |
145 | Ghaderi, R., Artursson, P., Carlfors, J., 1999. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS). Pharm. Res. 16, 676-681. DOI |
146 | Ghaste, R., C., D.D., Shah, R.R., Ghodke, D.S., 2009. Solid Dispersions : An Overview. Pharmaceutical Reviews. 7. |